Back in 2019, AI attracted attention for producing quirky, weird content. By 2022, it was producing occasionally passable ...

At first, I thought the on-case touch remote controls on Audien’s new Atom X OTC hearing aids ($389) were just a gimmick to differentiate them from other non-self-fitting budget over-the-counter (OTC) ...

For quantum computers to outperform their classical counterparts, they need more quantum bits, or qubits. State-of-the-art quantum computers have around 1,000 qubits. Columbia physicists Sebastian ...

Cosmos maintains a $1 billion valuation despite a steep weekly correction. The community has begun a structured research process to redesign ATOM’s economy. Early charts show ATOM holding a critical ...

An advanced nuclear startup just achieved a milestone as it races to meet an ambitious Department of Energy goal. Founded just over two years ago in July 2023, El Segundo-based Valar Atomics announced ...

The Potensic Atom 2 is a fantastic little drone with some impressive features and good image quality. Some of the features on offer come with caveats, but they're not necessarily deal breakers. Why ...

Not tunable. Hearing support is very blunt. Not a great value considering the whole package. Audien has repeatedly tried again in this low-end part of the market, cranking out at least five models of ...

Most of us take hearing for granted, but not everyone enjoys that privilege. Conversations start to feel like guessing games, laughter seems far away, and the soft background sounds that make life ...

Atom Therapeutics is touting data from a phase 2b/3 study as evidence that its gout drug has the efficacy and safety profile to stand out from the competition. The Chinese biotech evaluated the oral ...

After a heavy bout of selling pressure during the early hours of July 24, ATOM demonstrated impressive resilience, rebounding from an intraday low of $4.47 to close the session at $4.77. The 7% swing ...